cancer

mRNA Vaccine Used to Fight Brain Tumour

- Adam Clare Leave a comment

Brain tumours are scary and very difficult to deal with, current treatments include invasive surgery and/or radiation. The advent of mRNA based vaccines is making a difference in how we can treat various brain cancers and the early results are looking promising. A team just found a way to get the body’s immune system to start to find and address cancer within the brain. While the results are not yet usable the outlook is very promising.

“The demonstration that making an mRNA cancer vaccine in this fashion generates similar and strong responses across mice, pet dogs that have developed cancer spontaneously and human patients with brain cancer is a really important finding, because oftentimes we don’t know how well the preclinical studies in animals are going to translate into similar responses in patients,” said Duane Mitchell, M.D., Ph.D., director of the UF Clinical and Translational Science Institute and the UF Brain Tumor Immunotherapy Program and a co-author of the paper. “And while mRNA vaccines and therapeutics are certainly a hot topic since the COVID pandemic, this is a novel and unique way of delivering the mRNA to generate these really significant and rapid immune responses that we’re seeing across animals and humans.”

Read more.

Cancer Causing Roundup Maker Monsanto Must Pay $2.25 Billion in Damages

- Adam Clare

Bayer, the corporate owner of Monsanto, must pay $2.25 billion in damages due to Monsanto’s product called Roundup. The chemical spray kills insects very quickly (which is really bad for the planet) and due to it being permitted to use on residential properties the harm it has caused seems pretty great. One regular user of the chemical soup got cancer due to it and sued the company, thus leading the court ordering the payment. The lesson here: don’t use pesticides on residential properties. It’s good to see a massive corporation being held to account for its damaging actions.

“The jury’s punitive damages award sends a clear message that this multi-national corporation needs top to bottom change,” they said, calling the verdict “a condemnation of 50 years of misconduct by Monsanto.”
…
The claims rest on the ingredient glyphosate, introduced as a herbicide by Monsanto in 1974, which inhibits a certain enzyme in most plants, preventing them from growing. Monsanto also introduced genetically modified crops that are resistant to glyphosate.

Read more.

A Diverse Diet may Starve some Cancers

- Adam Clare

beans

Cancer is awful and destroys far too many lives, but what if we can help people survive by augmenting their medicine with better diets? New research is revealing that a diverse diet could help people essentially starve cancer. To be very clear: a diet change will not defeat cancer. The key takeaway here is that some medication can be more effective if matched with a diet that promotes healthy cells in your body which also stymies the development of cancer cells. We still have a long way to go when it comes to fighting cancer, but new developments every year help us on this healthy journey.

Seventy percent of T cells — the body’s most potent cancer-fighting immune cell — live along the gastrointestinal tract, making them highly sensitive to what you eat and what medicines you take. Over the last five years, scientists have started to understand how the gut microbiome influences T cells and the immune system, and how that can affect health and disease.
The general consensus seems to be that more diversity in gut bacteria is better, and, many of the studies looking at what the gut of a cancer treatment responder looks like differ in terms of which types of bacteria are present, driving home that no single strain is overly important. The one consistent finding is that people with more diversity in their gut bacteria seem to have better responses to immunotherapy.

Read more.

Reduce Your Cancer Risk by Eating Earlier

- Adam Clare

fries

A new study has concluded that when we eat our supper is an important factor in reducing risk of certain cancers. The researchers monitored people’s eating times and noticed that prostate and breast cancer risk was connected to later dinners. Your final meal of the day should ideally be before 9pm and two hours before you go to sleep. What’s really neat about this research is that doctors may start considering cancer treatment via diet in addition to modern therapies.

“Our study concludes that adherence to diurnal eating patterns is associated with a lower risk of cancer,” explained ISGlobal researcher Manolis Kogevinas, lead author of the study. The findings “highlight the importance of assessing circadian rhythms in studies on diet and cancer”, he added.

If the findings are confirmed, Kogevinas noted, “they will have implications for cancer prevention recommendations, which currently do not take meal timing into account”. He added: “The impact could be especially important in cultures such as those of southern Europe, where people have supper late.”

Read more.

Lower Your Risk of Cancer and Heart Disease by Cycling to Work

- Adam Clare

Bicycle

We all know that encouraging bicycles as daily transportation is good for cities, economies, and traffic flow. Cycling is really good for you too and the evidence that you should bike more is more prevalent than ever. The most recent contribution to why riding a bike to work is good for you comes from Glasgow. Researchers there found that over the course of five years people who biked regularly had lower instances of cancer and heart disease!

But, during the course of the study, regular cycling cut the risk of death from any cause by 41%, the incidence of cancer by 45% and heart disease by 46%.
The cyclists clocked an average of 30 miles per week, but the further they cycled the greater the health boon.
Walking cut the odds of developing heart disease but the benefit was mostly for people walking more than six miles per week.
“This is really clear evidence that people who commute in an active way, particularly by cycling, were at lower risk,” Dr Jason Gill, from the University of Glasgow, told the BBC News website.

Read more.

Scroll To Top